These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

110 related items for PubMed ID: 18052620

  • 1. Validation of high-performance liquid chromatography methods for determination of zidovudine, stavudine, lamivudine and indinavir in human plasma.
    Tarinas A, Tápanes RD, Ferrer G, Pérez J.
    Farm Hosp; 2007; 31(4):243-7. PubMed ID: 18052620
    [Abstract] [Full Text] [Related]

  • 2. Simultaneous determination of stavudine and lamivudine in human plasma by high performance liquid chromatography and its application to a bioavailability study.
    Wattananat T, Prasanchaimontri IO, Akarawut W.
    Southeast Asian J Trop Med Public Health; 2010 Mar; 41(2):369-77. PubMed ID: 20578520
    [Abstract] [Full Text] [Related]

  • 3. Simultaneous determination of the HIV nucleoside analogue reverse transcriptase inhibitors lamivudine, didanosine, stavudine, zidovudine and abacavir in human plasma by reversed phase high performance liquid chromatography.
    Verweij-van Wissen CP, Aarnoutse RE, Burger DM.
    J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Feb 25; 816(1-2):121-9. PubMed ID: 15664342
    [Abstract] [Full Text] [Related]

  • 4. A rapid and sensitive method for simultaneous determination of lamivudine and zidovudine in human serum by on-line solid-phase extraction coupled to liquid chromatography/tandem mass spectrometry detection.
    Estrela Rde C, Salvadori MC, Suarez-Kurtz G.
    Rapid Commun Mass Spectrom; 2004 Feb 25; 18(10):1147-55. PubMed ID: 15150840
    [Abstract] [Full Text] [Related]

  • 5. Simultaneous quantitation of the 5'-triphosphate metabolites of zidovudine, lamivudine, and stavudine in peripheral mononuclear blood cells of HIV infected patients by high-performance liquid chromatography tandem mass spectrometry.
    Moore JD, Valette G, Darque A, Zhou XJ, Sommadossi JP.
    J Am Soc Mass Spectrom; 2000 Dec 25; 11(12):1134-43. PubMed ID: 11118121
    [Abstract] [Full Text] [Related]

  • 6. Determination of zidovudine/lamivudine/nevirapine in human plasma using ion-pair HPLC.
    Fan B, Stewart JT.
    J Pharm Biomed Anal; 2002 Jun 01; 28(5):903-8. PubMed ID: 12039632
    [Abstract] [Full Text] [Related]

  • 7. High throughput LC-MS/MS method for simultaneous quantification of lamivudine, stavudine and nevirapine in human plasma.
    Mistri HN, Jangid AG, Pudage A, Gomes N, Sanyal M, Shrivastav P.
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Jun 15; 853(1-2):320-32. PubMed ID: 17481969
    [Abstract] [Full Text] [Related]

  • 8. Development and validation of an HPLC-UV method for simultaneous determination of zidovudine, lamivudine, and nevirapine in human plasma and its application to pharmacokinetic study in human volunteers.
    Nandi U, Das A, Roy B, Choudhury H, Gorain B, Pal TK.
    Drug Test Anal; 2013 Jun 15; 5(6):485-91. PubMed ID: 22374835
    [Abstract] [Full Text] [Related]

  • 9. Simultaneous determination of lamivudine, stavudine and nevirapine in human plasma by LC-MS/MS and its application to pharmacokinetic study in clinic.
    Li Z, Ding C, Ge Q, Zhou Z, Zhi X, Liu X.
    Biomed Chromatogr; 2010 Sep 15; 24(9):926-34. PubMed ID: 20058328
    [Abstract] [Full Text] [Related]

  • 10. Determination of lamivudine/stavudine/efavirenz in human serum using liquid chromatography/electrospray tandem mass spectrometry with ionization polarity switch.
    Fan B, Bartlett MG, Stewart JT.
    Biomed Chromatogr; 2002 Sep 15; 16(6):383-9. PubMed ID: 12228894
    [Abstract] [Full Text] [Related]

  • 11. Continued lamivudine versus delavirdine in combination with indinavir and zidovudine or stavudine in lamivudine-experienced patients: results of Adult AIDS Clinical Trials Group protocol 370.
    Kuritzkes DR, Bassett RL, Johnson VA, Marschner IC, Eron JJ, Sommadossi JP, Acosta EP, Murphy RL, Fife K, Wood K, Bell D, Martinez A, Pettinelli CB.
    AIDS; 2000 Jul 28; 14(11):1553-61. PubMed ID: 10983642
    [Abstract] [Full Text] [Related]

  • 12. Simultaneous determination of zidovudine and lamivudine in human serum using HPLC with tandem mass spectrometry.
    Kenney KB, Wring SA, Carr RM, Wells GN, Dunn JA.
    J Pharm Biomed Anal; 2000 Jul 28; 22(6):967-83. PubMed ID: 10857566
    [Abstract] [Full Text] [Related]

  • 13. A comparison of stavudine plus lamivudine versus zidovudine plus lamivudine in combination with indinavir in antiretroviral naive individuals with HIV infection: selection of thymidine analog regimen therapy (START I).
    Squires KE, Gulick R, Tebas P, Santana J, Mulanovich V, Clark R, Yangco B, Marlowe SI, Wright D, Cohen C, Cooley T, Mauney J, Uffelman K, Schoellkopf N, Grosso R, Stevens M.
    AIDS; 2000 Jul 28; 14(11):1591-600. PubMed ID: 10983646
    [Abstract] [Full Text] [Related]

  • 14. An open randomized controlled trial of zidovudine plus lamivudine versus stavudine plus lamivudine.
    Foudraine NA, de Jong JJ, Jan Weverling G, van Benthem BH, Maas J, Keet IP, Jurriaans S, Roos MT, Vandermeulen K, de Wolf F, Lange JM.
    AIDS; 1998 Aug 20; 12(12):1513-9. PubMed ID: 9727573
    [Abstract] [Full Text] [Related]

  • 15. Validation of a sensitive LC/MS/MS method for the determination of zidovudine and lamivudine in human plasma.
    Rower JE, Klein B, Bushman LR, Anderson PL.
    Biomed Chromatogr; 2012 Jan 20; 26(1):12-20. PubMed ID: 21465499
    [Abstract] [Full Text] [Related]

  • 16. A comparison of stavudine, didanosine and indinavir with zidovudine, lamivudine and indinavir for the initial treatment of HIV-1 infected individuals: selection of thymidine analog regimen therapy (START II).
    Eron JJ, Murphy RL, Peterson D, Pottage J, Parenti DM, Jemsek J, Swindells S, Sepulveda G, Bellos N, Rashbaum BC, Esinhart J, Schoellkopf N, Grosso R, Stevens M.
    AIDS; 2000 Jul 28; 14(11):1601-10. PubMed ID: 10983647
    [Abstract] [Full Text] [Related]

  • 17. Durable HIV-1 suppression with indinavir after failing lamivudine-containing double nucleoside therapy: a randomized controlled trial.
    Foudraine NA, Jurriaans S, Weverling GJ, Burger DM, Hoetelmans RM, Roos MT, Maas J, Miedema F, Reiss P, Portegies P, de Wolf F, Lange JM.
    Antivir Ther; 2001 Mar 28; 6(1):55-62. PubMed ID: 11417762
    [Abstract] [Full Text] [Related]

  • 18. Exploring dried blood spot sampling technique for simultaneous quantification of antiretrovirals: lamivudine, stavudine and nevirapine in a rodent pharmacokinetic study.
    Nirogi R, Kandikere V, Komarneni P, Aleti R, Padala N, Kalaikadhiban I, Bhyrapuneni G, Muddana N.
    Biomed Chromatogr; 2012 Dec 28; 26(12):1472-81. PubMed ID: 22344535
    [Abstract] [Full Text] [Related]

  • 19. Determination of lamivudine, zidovudine, and nevirapine in capillary blood sampled on filter paper by LC.
    Malm M, Römsing S, Obua C, Bergqvist Y.
    J Chromatogr Sci; 2009 Dec 28; 47(10):855-62. PubMed ID: 19930794
    [Abstract] [Full Text] [Related]

  • 20. Cerebrospinal-fluid HIV-1 RNA and drug concentrations after treatment with lamivudine plus zidovudine or stavudine.
    Foudraine NA, Hoetelmans RM, Lange JM, de Wolf F, van Benthem BH, Maas JJ, Keet IP, Portegies P.
    Lancet; 1998 May 23; 351(9115):1547-51. PubMed ID: 10326538
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.